| BCBS Federal Medical & Drug | 5.30.097 Growth Hormone Long-Acting | 2025-12-12 |
| BCBS Federal Medical & Drug | 5.30.098 Growth Hormone Short-Acting | 2025-12-12 |
| BCBS Federal Medical & Drug | 5.45.002 Xolair (omalizumab) | 2025-12-12 |
| BCBS Federal Medical & Drug | 5.45.007 IL-5 Antagonists (IgG1 kappa) | 2025-12-12 |
| BCBS Federal Medical & Drug | 5.45.013 Xhance (fluticasone) | 2025-12-12 |
| BCBS Federal Medical & Drug | 5.45.015 Tezspire (tezepelumab-ekko) | 2025-12-12 |
| BCBS Federal Medical & Drug | 5.50.013 Trulance (plecanatide) | 2025-12-12 |
| BCBS Federal Medical & Drug | 5.50.021 H. pylori Infection Agents | 2025-12-12 |
| BCBS Federal Medical & Drug | 5.50.026 Ibsrela (tenapanor) | 2025-12-12 |
| BCBS Federal Medical & Drug | 5.50.040 Iqirvo (elafibranor) | 2025-12-12 |